Sean Harper

Dr. Sean Harper

Ending Migraine Pain

In May, Aimovig, a drug Harper developed at biotech company Amgen, became the first migraine-­prevention drug to receive FDA approval. Aimovig limits the number and severity of migraines with a monthly injection, and eliminated migraines in some patients. —Robin Marty

TIME may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.